← Back to Search

Other

Standard treatment + Microcurrent Therapy for Pain

N/A
Waitlist Available
Research Sponsored by Paul Crawford
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up screening, time 0 (week 0), time 1 (week 1), time 2 (week 2), time 3 (week 3), time 4 (week 4), time 5 (week 5), time 6 (week 12)

Summary

This trial compares standard pain treatment with and without microcurrent therapy in primary care patients. It aims to see if microcurrent therapy can be more effective in reducing pain by using tiny electrical currents to stimulate healing. Microcurrent therapy has been studied for its potential to increase function and decrease pain in people with acute knee pain.

Eligible Conditions
  • Pain
  • Opioid Use Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~screening
This trial's timeline: 3 weeks for screening, Varies for treatment, and screening for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Defense and Veterans Pain Rating Scale (DVPRS)
Measure Yourself Medical Outcome Profile (MYMOP)
Patient-Reported Outcomes Information System (PROMIS) -57 Profile standardized T-Scores
Secondary study objectives
Opioids taken

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Standard treatment + Microcurrent TherapyExperimental Treatment1 Intervention
100-300µA microcurrent delivered for 20-300 minutes, once a week for 6 weeks
Group II: Standard treatment + placeboPlacebo Group1 Intervention
Placing the microcurrent pads on the patient but not turning on the microcurrent box for 30 minutes once a week for 6 weeks
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Standard treatment + Microcurrent Therapy
2019
N/A
~200

Find a Location

Who is running the clinical trial?

Paul CrawfordLead Sponsor
5 Previous Clinical Trials
767 Total Patients Enrolled
~34 spots leftby Nov 2025